Hematology-Oncology Associates of the Quad-Cities, PC
Leukemia Trials
CALGB 10501 A Phase III Intergroup CLL Study of Asymptomatic Patients with Untreated Chronic Lymphocytic Leukemia Patients Randomized To Early Intervention Versus Observation with Later Treatment in the High Risk Genetic Subset with IgVH Unmutated Disease .
E2902: A Phase III Randomized Study of Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subsequent Remission or in Remission after Primary Induction Failure or Patients Over Age 60 in First Remission.
CALGB 10404 A Randomized Phase II Study of Three Fludarabine/Antibody Combinations for Patients with Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia.
Connect CLL: The Chronic Lymphocytic Disease Registry
E2902: A Phase III Randomized Study of Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subsequent Remission or in Remission after Primary Induction Failure or Patients Over Age 60 in First Remission.
CALGB 10404 A Randomized Phase II Study of Three Fludarabine/Antibody Combinations for Patients with Symptomatic, Previously Untreated Chronic Lymphocytic Leukemia.
Connect CLL: The Chronic Lymphocytic Disease Registry
